Vaccinating in the Emergency Department, a Model to Overcome Influenza Vaccine Hesitancy. Pediatr Qual Saf 2021;6(2):e430
Date
04/16/2021Pubmed ID
33855251Pubmed Central ID
PMC8032353DOI
10.1097/pq9.0000000000000430Scopus ID
2-s2.0-85124524673 (requires institutional sign-in at Scopus site) 6 CitationsAbstract
INTRODUCTION: Vaccine hesitancy and delays in vaccine administration time have limited the success of prior influenza vaccination initiatives in the pediatric emergency department (ED). In 2018-2019, season 1, this ED implemented mandatory vaccine screening and offered the vaccine to all eligible patients; however, only 9% of the eligible population received the vaccine. In 2019-2020, season 2, the team sought to improve influenza vaccination rates from 9% to 15% and administer over 2,000 vaccines to eligible ED patients.
METHODS: Key drivers included: identifying vaccine hesitancy, providing counseling, reducing administration delays, and developing reminders for vaccine administration. We tested interventions using plan-do-study-act cycles. We included discharged ED patients, age 6 months-18 years old, emergency severity index score 2-5, and no prior vaccine this season. Process measures included percent of patients screened, eligible, accepting the vaccine, and leaving before vaccination. Outcome measures were the percent of eligible patients vaccinated and the total number of vaccines administered. Vaccination time was the balancing measure.
RESULTS: We included 57,804 children in this study. Comparing season 1 to 2, screening rates (84%) and eligibility rates (58%) were similar. Vaccine acceptance rates improved from 13% to 22%, the proportion of patients leaving before vaccination decreased from 32% to 17%, and vaccination rates improved from 9% to 20%. Total vaccines administered increased from 1,309 to 3,180, and vaccination time was 5 minutes faster in season 2.
CONCLUSIONS: This ED influenza vaccination process provides a model to overcome vaccine hesitancy and can be adapted and replicated for any vaccine-preventable illness.
Author List
Baumer-Mouradian SH, Servi A, Kleinschmidt A, Nimmer M, Lazarevic K, Hanson T, Jastrow J, Jaworski B, Kopetsky M, Drendel ALAuthors
Shannon H. Baumer-Mouradian MD Associate Professor in the Pediatrics department at Medical College of WisconsinAmy L. Drendel DO Interim Chief, Professor in the Pediatrics department at Medical College of Wisconsin
